95 results found.
        
Top 10 Takeaways from Orthopedics in 2019
 
Entry Into Joint Replacement a Major Step in Globus Medical’s Evolution
By Mike Evers In October, we sat down with leaders from Globus Medical to discuss their surprising entrance into the joint replacement market and robotics’ role in orthopedic surgery. As a quick refresher, during 2Q19 Globus Medical announced that it had acquired substantially all...
Enabling Technology and Integrated Selling Strategies Drove Orthopedic Growth in the Third Quarter
The third quarter of 2019 brought some standout performances from large players like Stryker, Medtronic, NuVasive and Globus Medical. DePuy Synthes and Zimmer Biomet made incremental progress in returning to market growth. Notably, the top performing players all have well-established enabling tec...
Conformis Continues Slide Due to Aetna Coverage Denials
Conformis reports 3Q19 revenue of USD $17.3MM, -40.3% vs. 3Q18.
Strength in Knee Replacement and Sports Medicine Drives Smith+Nephew Growth
Smith+Nephew reports 3Q19 orthopedic revenue of USD $852MM, +4.7% vs. 3Q18.
Smith+Nephew CEO Stepping Down
Smith+Nephew CEO Namal Nawana will step down from his position on October 31, by mutual agreement, to pursue opportunities outside of the U.K.
Orthopedic Public Companies Grow 2.6% YoY in Quarter
By Mike Evers The second quarter of 2019 brought incremental improvement over the first. Year over year revenue grew 2.6% in the quarter for the public companies reported herein compared to 1.1% last quarter. The five largest orthopedic players, which control 58% of the market, showed a...
Smith & Nephew Up +1.6% in 2Q19 on Sports Medicine
Smith & Nephew reports 2Q19 orthopedic revenue of USD $892MM, +1.6% vs. 2Q18.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Robotics Recap: Orthopedic Executives Remain Bullish
By Mike Evers   Despite normal seasonal softness in capital sales, the first quarter of 2019 was an active one for robotic and digital surgery developments. New entrants into the orthopedic robot market like Zimmer Biomet’s ROSA Knee may lead to longer buying cycles as ...
Global Orthopedic Market Revenue to Exceed $61 Billion in 2023
The global orthopedic market will exceed US $61 billion in revenue in 2023.
Future-Minded Orthopedic and Spine Surgeons Will Advise Industry Stakeholders and Manufacturing Community at OMTEC® 2019
Future-minded orthopedic and spine surgeons will advise industry stakeholders and the manufacturing community at OMTEC® 2019
Smith & Nephew Reports 1Q19 Orthopedic Revenue of $879MM, +0.9% vs. 1Q18
Smith & Nephew reports 1Q19 orthopedic revenue of USD $879MM, +0.9% vs. 1Q18.
Orthopedic Industry Revenue Reaches $51 Billion in 2018
By Mike Evers Download Your Copies
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
Smith & Nephew Reports 4Q18 Orthopedic Revenue of $911.8MM, +1.4% vs. 4Q17
Smith & Nephew reports 4Q18 orthopedic revenue of USD $911.8MM, +1.4% vs. 4Q1...
ConforMIS Reports 4Q18 Revenue of $22MM, +6.3% vs. 4Q17
ConforMIS posts 4Q18 revenue of USD $22MM, +6.3% vs 4Q17, with 2018 full ye...
ConforMIS, Orthofix and OrthoPediatrics Report Preliminary 4Q18 and FY 2018 Results
Preliminary results for ConforMIS, Orthofix and OrthoPediatrics were mixed. While ConforMIS’ net revenue for the year grew in the double digits, adjusting for product-only revenue reveals a mostly flat year. Orthofix rode strong spinal implant sales to mid-...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
Smith & Nephew Reports 3Q18 Orthopaedic Revenue of $808.7MM, +2.0% vs. 3Q17
Smith & Nephew reports 3Q18 orthopaedic revenue of US $808.7MM, +2.0% vs. 3Q17
ConforMIS Reports 3Q18 Product Revenue of $18.3MM, +0.9% vs. 3Q17
ConforMIS posts 3Q18 product revenue of US $18.3MM, +0.9% vs 3Q17.
Zimmer Biomet Names Ivan Tornos New Group President, Orthopedics
Zimmer Biomet appointed Mr. Ivan Tornos as Group President, Orthopedics, effective November 1.
Joint Reconstruction Expected to Continue with Steady Growth
By Carolyn LaWell Joint reconstruction accounts for 37% of the global orthopaedic industry. We estimate that joint reconstruction product revenue surpassed $18 billion in 2017, an increase of $560.3 million or 3.2% vs. 2016. These numbers were published in
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group